MIMRELSA

Serial Number 97696650
733

Registration Progress

Application Filed
Nov 29, 2022
Under Examination
Oct 24, 2023
Approved for Publication
Aug 29, 2023
Published for Opposition
Aug 29, 2023
Registered

Trademark Image

MIMRELSA

Basic Information

Serial Number
97696650
Filing Date
November 29, 2022
Published for Opposition
August 29, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Oct 20, 2025
Application
Pending
Classes
005 042 044

Rights Holder

Protagonist Therapeutics, Inc.

03
Address
Suite 140
7707 Gateway Boulevard
Newark, CA 94560-1160

Ownership History

Protagonist Therapeutics, Inc.

Original Applicant
03
Newark, CA

Protagonist Therapeutics, Inc.

Owner at Publication
03
Newark, CA

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
Oct 21, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 20, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 20, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 20, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 15, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 15, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 15, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 11, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 11, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 11, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 11, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 12, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 12, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 24, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 29, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 29, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 9, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 20, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 18, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 17, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 17, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 26, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 26, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 26, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 25, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 5, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 5, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 5, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 22, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 2, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders
Class 042
Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
Class 044
Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders

Classification

International Classes
005 042 044